Americas · Regional markets · Financial Post

Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026

Published by Financial Post · Canada 1 h ago

Topline data readout from APPROACH Phase 3 study of HLP003 in development for the potential adjunctive treatment of major depressive disorder (“MDD”) on track for Q4 20261,2…

Read the full article on Financial Post Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (financialpost.com)

Also worth reading

BNN Bloomberg

Gordon Reid’s Top Picks for Oct. 21, 2026

El Cronista

No tires las botellas de plástico: cómo hacer un sistema de riego casero para las plantas del jardín

Gestión

Keiko Fujimori manifestó que esperaba recibir mayores facultades legislativas

Ámbito

El dólar cayó, pero completó 85 jornadas consecutivas por encima de $ 40

Diario Financiero

Negociador de EEUU en Moscú propone celebrar cumbre entre Trump, Putin y Xi Jinping el próximo mes

Portafolio